Richard C. Yocum

2005 - Halozyme Therapeutics

In 2005, Richard C. Yocum earned a total compensation of $220.5K as Vice President — Clinical Development and Medical Affairs at Halozyme Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$37,500
Option Awards$42,455
Salary$140,430
Other$84
Total$220,469

Yocum received $140.4K in salary, accounting for 64% of the total pay in 2005.

Yocum also received $37.5K in non-equity incentive plan, $42.5K in option awards and $84 in other compensation.

Rankings

In 2005, Richard C. Yocum's compensation ranked 186th out of 262 executives tracked by ExecPay. In other words, Yocum earned more than 29.0% of executives.

ClassificationRankingPercentile
All
186
out of 262
29th
Division
Manufacturing
70
out of 97
28th
Major group
Chemicals And Allied Products
21
out of 29
28th
Industry group
Drugs
16
out of 24
33rd
Industry
Biological Products, Except Diagnostic Substances
6
out of 6
0th
Source: SEC filing on April 3, 2008.

Yocum's colleagues

We found three more compensation records of executives who worked with Richard C. Yocum at Halozyme Therapeutics in 2005.

2005

Jonathan Lim

Halozyme Therapeutics

Chief Executive Officer

2005

Gregory Frost

Halozyme Therapeutics

Chief Scientific Officer

2005

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

You may also like